Axsome Therapeutics, Inc. (AXSM)
209.87
+7.04
(+3.47%)
USD |
NASDAQ |
Sep 02, 16:00
209.87
0.00 (0.00%)
After-Hours: 16:04
Axsome Therapeutics Cash from Operations (Annual) : -93.40M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -93.40M |
| December 31, 2024 | -128.41M |
| December 31, 2023 | -145.08M |
| December 31, 2022 | -116.51M |
| December 31, 2021 | -108.54M |
| December 31, 2020 | -78.46M |
| December 31, 2019 | -46.38M |
| Date | Value |
|---|---|
| December 31, 2018 | -30.05M |
| December 31, 2017 | -26.47M |
| December 31, 2016 | -21.28M |
| December 31, 2015 | -7.439M |
| December 31, 2014 | -4.596M |
| December 31, 2013 | -1.631M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Eli Lilly & Co. | 16.81B |
| Liquidia Corp. | -35.69M |
| Filana Therapeutics, Inc. | -32.25M |
| CorMedix, Inc. | 175.05M |
| Eloxx Pharmaceuticals, Inc. | -6.327M |